Adherium Limited announced that it has appointed Peter Stratford as Chief Executive Officer (CEO), effective 22 November 2019. Mike Motion has simultaneously been appointed Chief Commercial Officer (CCO). The transition means that interim CEO Jeremy Curnock Cook and interim CCO Bill Hunter have relinquished these roles as the company embarks on its new platform of product development and commercialization.

Both remain as Non-executive Directors on the company board. Most recently, Dr. Stratford was Head of Innovation at BTG, which he joined in January 2011 following the acquisition of Biocompatibles International plc.